CM529D1
/ Keymed Biosciences
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 24, 2026
Study of CM529D1 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=128 | Not yet recruiting | Sponsor: Keymed Biosciences Co.Ltd
New P1/2 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1